glp-1 obesity drug news today october 23 2025 New Daily Weight Loss Pill Aims to Take on Ozempic The Obesity-Drug Revolution Is Stalling

Doses are titrated gradually to balance glycemic control with tolerability

Semaglutide The first GLP1-receptor agonist to be made available both orally and by subcutaneous injection was semaglutide

Except for oral semaglutide, theyre typically subcutaneous injections (administered into the fatty tissue just under the skin)

[DOI] [PubMed] [Google Scholar] 182.Laux G., Berger S., Szecsenyi J., Kaufmann-Kolle P., Leutgeb R

As mentioned, GLP-1RAs are increasingly used in the treatment of T2MD owing to their following advantages: lowering of the levels of blood glucose, reducing body weight, improving the function of islet, and exerting potential cardiovascular benefits (206)

If that matches your vial, great